Cardio Drug Promising for Treatment of Leukemias with Mutations Linked to ROCK Pathway
September 21, 2011
Cardio Drug Promising for Treatment of Leukemias with Mutations Linked to ROCK Pathway
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter - Prostate Cancer Risk Markers Show Promise for Test to ID Elevated Risk in Men with Benign Hyperplasia
April 3, 2013 / Pharmacogenomics Reporter - MDxHealth and Ghent University Begin Collaboration under New Pharmacoepigenomics Center
December 12, 2012 / Pharmacogenomics Reporter - Study Finds Dopamine Gene Variant Predictive of Placebo Response in IBS Patients
October 24, 2012 / Pharmacogenomics Reporter - Prospective Study Suggests Site-Specific Treatment after BioTheranostics' CUP Testing Improves Survival
October 17, 2012 / Pharmacogenomics Reporter